News from NORD

NORD and Neurology Reviews Publish Special Report


 

NORD and Neurology Reviews together have published the third annual Rare Neurological Disease Special Report in print and digital editions to promote awareness and understanding of rare neurological diseases among medical professionals. The publication includes articles on the efficacy of cannabis in treating children with rare and refractory epilepsy, delays in diagnosis and treatment of infantile spasms, telemedicine, new and potential therapies for rare neuromuscular disorders, and the clinical therapeutic potential of gene therapy.

Recommended Reading

GAO to launch investigation of FDA’s Orphan Drug program
MDedge Endocrinology
NORD Awards Grants for Rare Disease Research
MDedge Endocrinology
NORD Publishes Basic Principles for Health Coverage Reform
MDedge Endocrinology
NORD Submits Letter to Congress on Pre-Existing Conditions
MDedge Endocrinology
NORD Unveils “Do Your Share for Rare” Year-Long Awareness Campaign
MDedge Endocrinology
Tickets Now On Sale for NORD’s 2017 Rare Impact Awards
MDedge Endocrinology
Osilodrostat maintained cortisol control in Cushing’s syndrome
MDedge Endocrinology
FDA approves first home genetic health risk test
MDedge Endocrinology
Most children with growth disorders benefit from growth hormone
MDedge Endocrinology
NORD Announces Recipients of 2017 Rare Impact Awards
MDedge Endocrinology